Related Experiment Video
Updated: Jan 9, 2026

07:44
A Porcine Model of Acute Autologous Pulmonary Embolism
Published on: September 6, 2024
746
Hypoxemia in pulmonary embolism, a clinical study.
The Journal of Clinical Investigation
|March 1, 1971
Summary
Hypoxemia after pulmonary embolism is primarily caused by shunt-like effects, likely due to atelectasis. These shunts gradually resolve over a month and are influenced by inspiratory capacity, especially in patients without pulmonary infarction.
Area of Science:
- Pulmonary Medicine
- Cardiovascular Physiology
Background:
- Acute pulmonary embolism (PE) can lead to hypoxemia.
- The underlying mechanisms of hypoxemia in PE require further elucidation, particularly in patients without pre-existing cardiopulmonary conditions.
Purpose of the Study:
- To investigate the causes of hypoxemia in patients following acute pulmonary embolism.
- To determine the relationship between hypoxemia, shunt-like effects, pulmonary vascular occlusion, and pulmonary artery pressure.
Main Methods:
- Studied 21 patients with acute PE and no prior heart or lung disease.
- Utilized pulmonary angiography to identify vascular filling defects.
- Assessed hypoxemia, shunt-like effects, inspiratory capacity, and pulmonary artery pressure.
Main Results:
- Hypoxemia was predominantly attributed to shunt-like effects.
- Shunt magnitude did not correlate with the extent of vascular occlusion or pulmonary artery pressure.
- Shunts tended to resolve over approximately one month; inspiratory maneuvers temporarily reduced shunting in patients without infarction.
Conclusions:
- Atelectasis appears to be the primary driver of right-to-left shunting in PE.
- Pulmonary vasoconstriction may not be a significant factor in human PE pathophysiology during the studied period.
- Inspiratory capacity influences shunt reversibility, particularly in the absence of pulmonary infarction.
Related Concept Videos
Pulmonary Embolism III: Nursing Management
325
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
325
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
281
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
281
Pulmonary Embolism I: Introduction
471
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
471
Acute Respiratory Failure-II
988
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
988
Hypoxia
1.9K
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
1.9K
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
564
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
564

